Worldwide Healthcare News

Medical Implants Market Report,  published by Allied Market Research, forecasts that the global market is expected to garner $116 billion by 2022.  Orthopaedic implant is expected to continue generating high revenue throughout the forecast period. North America led the market in 2015 and is expected to remain dominant during the study period. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/71?utm_source=Blogger&utm_medium=Niranjan The major factors boosting the market growth include technological advancements [such as bioabsorbable stents], rising incidence of chronic diseases, and increasing geriatric population worldwide. Improved patient awareness and rise in disposable incomes in the developing countries would further increase the adoption of medical implants. Huge market opportunities in the emerging nations and rise in development of minimally invasive and non-surgical procedures are expected to foster the demand for medic...

According to a new report published by Allied Market Research, titled,  Hernia Repair Devices and Consumables Market, by Product, Surgery Type, and Hernia Type: Global Opportunity Analysis and Industry Forecast, 2017-2023,"  the global hernia repair devices and consumables market was valued at $4,156 million in 2016, and is projected to reach $5,554 million in 2023, registering a CAGR of 4.2% from 2017 to 2023. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/353?utm_source=Blogger&utm_medium=Niranjan  Hernia is a medical condition in which the internal organs of the body protrude due to weakened abdominal wall. It is classified in five different types, inguinal hernia, incisional hernia, femoral hernia, umbilical hernia, and others (hiatal hernia and epigastric hernia). Hernia repair is one of the most commonly performed surgical procedures, requiring hernia fixation devices such as tacks or staples and consumables. The f...

Therapeutic proteins and peptides are an important class of drugs, which serve patients in need of novel therapies. Approved oral proteins and peptides drugs are indicated to treat a wide array of clinical indications, including diabetes, gastric & metabolic disorders, and hormonal disorders. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/378?utm_source=Blogger&utm_medium=Niranjan The major factors that drive the growth of the global oral proteins and peptides market include increase in collaborative efforts between pharmaceutical companies, surge in prevalence of chronic conditions, increase in elderly population, and rise in awareness & preference among populace for oral proteins and peptide-based drugs. However, high cost associated with drug development and low bioavailability of these drugs impede the market growth. Conversely, increase in novel indications for known oral protein therapeutics, high R&D investment by ph...

A mechanical ventilator is a machine designed to facilitate breathable air into and out of the lungs, to provide breathing for a patient who is physically unable to breathe or is breathing insufficiently. It comprises a control system, flexible breathing circuit, monitors, and alarms. It is one of the most common medical devices deployed in intensive care units of hospitals. The expanding geriatric population who is prone to respiratory disorders significantly drives the growth of the mechanical ventilator market. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/453?utm_source=Blogger&utm_medium=Niranjan In addition, escalating government expenditures in healthcare that promote adoption of mechanical ventilators in the developing countries, such as China and India, propel the market growth. The swelling number of intensive care units was observed in China in 2016, which led the government to continue to be a large buyer. Such circumstances...

Small Animal Imaging (In-Vivo) Market   report, published by Allied Market Research, forecasts that the global market is expected to garner $2.1 Billion by 2020, registering a CAGR of 9.1% during the forecast period 2014 to 2020.  Optical imaging modality is and would continue to be the most preferred imaging technology for clinical research organizations (CROs) through 2020, largely due to high sensitivity, economic pricing and a broad scope of applications. Such factors would eventually push the optical imaging technology segment to contribute about 40% of the global small animal imaging market revenue by 2020. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/474?utm_source=Blogger&utm_medium=Niranjan Rising number of pre-clinical research, increasing investments by the CROs in the research activities, a growing number of multi-functional pre-clinical imaging and technological advancements, namely combination of high resolution...

Autoimmune disease therapeutics include different types of drugs such as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, immune suppressants, corticosteroids, beta-blockers, and others. The demand for autoimmune disease therapeutics is estimated to increase during the forecast period owing to surge in prevalence of autoimmune disease, advancement in screening & diagnosis procedures, and wide availability of advanced therapeutics. Moreover, strong presence of pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others is expected to further boost the market growth. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5185?utm_source=Blogger&utm_medium=Niranjan According to a new report published by Allied Market Research, titled, " Autoimmune Disease Therapeutics Market  by Drug Class, Ind...

Acute lymphocytic/lymphoblastic leukemia therapeutics market size was valued at $2,334.5 million in 2018, and is projected to reach $3,528.8 million by 2026, growing at a CAGR of 5.3% from 2019 to 2026. Acute lymphocytic/lymphoblastic leukemia (ALL) is one of the types of leukemia, which is highly prevalent in pediatrics and also observed in adults. There are various therapy options for ALL treatment including chemotherapy, targeted therapy, and immunotherapy. ALL treatments witness high success rates in pediatric population, however, in adult population have low success rates. Chemotherapy is a first line treatment option in majority of ALL cases. Rise in incidences of acute lymphoblastic leukemia and the number of bone marrow biopsies across the world are the major factors that boost the growth of the acute lymphocytic/lymphoblastic leukemia therapeutics market. However, the stringent regulatory approvals for the therapeutics and the adverse side effect of the drugs used in th...